NCT01553981View on ClinicalTrials.gov

A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Lung Diseases, Interstitial
Interventions
DRUG

Tadalafil

Tab. Tadalafil 20 mg every other day for 6 months

DRUG

Placebo

Shape , size, color and odor matched Tab. of inert material every other day for 6 months

Trial Locations (1)

226014

SGPGIMS, Lucknow

All Listed Sponsors
lead

Sanjay Gandhi Postgraduate Institute of Medical Sciences

OTHER_GOV

NCT01553981 - A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma | Biotech Hunter | Biotech Hunter